AQP4-IgG or MOG-IgG from the systemic circulation may enter the CNS through a disrupted blood–brain barrier, potentially initiating primary inflammatory events and damaging astrocytes, while GFAP autoimmunity may occur as a secondary phenomenon. This evidence concerns the gene GFAP and Autoimmunity.